TCM
MDGL icon

TCG Crossover Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

TCG Crossover Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-149,283
Closed -$41.8M – 38
2024
Q2 		$41.8M Hold
149,283
– – 4.36% 7
2024
Q1 		$39.9M Sell
149,283
-30,634
-17% -$7.22M 3.15% 15
2023
Q4 		$41.6M Hold
179,917
– – 4.62% 10
2023
Q3 		$26.3M Buy
179,917
+30,000
+20% +$5.65M 3.87% 14
2023
Q2 		$34.6M Hold
149,917
– – 5.68% 7
2023
Q1 		$36.3M Sell
149,917
-138,137
-48% -$37.6M 7.08% 4
2022
Q4 		$83.6M Buy
288,054
+258,054
+860% +$25.2M 14.76% 2
2022
Q3 		$1.95M Buy
+30,000
New +$2.08M 0.58% 19

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return